Apply to trial NCT06539624

A few quick questions so the study team can decide if you might be a fit.

RecruitingGenetic intervention

Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

Objective: To explore the safety and tolerability of different doses of EXG110 with Fabre disease

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We forward your profile to the study team

    They see only the answers needed to decide if you can be screened.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email so you can come back later, and the study team uses it to reach you.

By clicking Start, you agree to our terms of service.